Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritis

Arthritis & Rheumatism

Volumn 36, Issue 3, 1993, Pages 329-335

  Walker, Alexander M ^{a,b,c,d,e,f,g}   Funch, Donnie ^{a,b,c,d,e,f,g}   Dreyer, Nancy A ^{a,b,c,d,e,f,g}   Tolman, Keith G ^{a,b,c,d,e,f,g}   Kremer, Joel M ^{a,b,c,d,e,f,g}   Alarcón, Graciela S ^{a,b,c,d,e,f,g}   Lee, Randall G ^{a,b,c,d,e,f,g}   Weinblatt, Michael E ^{a,b,c,d,e,f,g}  

^a Epidemiology Resources Inc   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; METHOTREXATE;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; MALE; METHOTREXATE; MIDDLE AGE; PROGNOSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0027523650     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780360307     Document Type: Article

References (16)

1. The liver in rheumatic diseases
2. Clinical associations between arthritis and liver disease
3. Low‐dose methotrexate therapy and hepatotoxicity: the view of the hepatologist
4. Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis
5. Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis
6. Liver biopsy findings in patients with rheumatoid arthritis undergoing long‐term treatment with methotrexate
7. Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy: a prospective study with baseline and sequential biopsy samples
8. Methotrexate guidelines: revised
9. Methotrexate‐associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis
10. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients
11. Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long‐term treatment
12. Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis: correlation with light microscopic findings
13. Liver biopsies from psoriatics related to methotrexate therapy: findings in post‐methotrexate liver biopsies from 160 psoriatics
14. Methotrexate hepatotoxicity in psoriasis: consideration of liver biopsies at regular intervals
15. Methotrexate and the liver
16. Long‐term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84‐month update